SCHEMBL20147219

SCHEMBL20147219

Cn1c2ccccc2c2cc(C=O)nc(-c3ccccc3C=O)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.42
ALDH1A1 P00352 2/20 0.38
IMPDH2 P12268 1/20 0.38
GPR3 P46089 1/20 0.37
ALKBH5 Q6P6C2 1/20 0.36
FTO Q9C0B1 1/20 0.36
HSP90AA1 P07900 1/20 0.36
IDO1 P14902 1/20 0.36
HDAC3 O15379 2/20 0.36
HDAC4 P56524 2/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC7 Q8WUI4 2/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC10 Q969S8 2/20 0.36
HDAC11 Q96DB2 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
HDAC9 Q9UKV0 2/20 0.36
HDAC5 Q9UQL6 2/20 0.36
L3MBTL1 Q9Y468 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24200436 0.83 KDM4E (0.40) AHRALDH1A1IMPDH2HDAC3HDAC4
SCHEMBL27979729 0.83 ALDH1A1 (0.47) AHRALDH1A1GPR3ALKBH5FTO
SCHEMBL24200425 0.80 ALKBH5 (0.41) AHRALDH1A1IMPDH2GPR3ALKBH5
SCHEMBL29925076 0.79 AHR (0.47) AHRALDH1A1IMPDH2GPR3ALKBH5
SCHEMBL27979863 0.79 AHR (0.47) AHRALDH1A1IMPDH2GPR3ALKBH5
SCHEMBL28540135 0.75 AHR (0.44) AHRALDH1A1IMPDH2GPR3ALKBH5
SCHEMBL9779016 0.72 AHR (0.51) AHRALDH1A1IMPDH2GPR3ALKBH5
SCHEMBL27979867 0.71 PGR (0.43) ALDH1A1KDM4ELMNAGAAKMT2A
SCHEMBL6710234 0.70 ALDH1A1 (0.46) ALDH1A1IMPDH2L3MBTL1TDP1KDM4E
SCHEMBL28839834 0.68 PTGER4 (0.47) ALDH1A1TDP1KDM4ELMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3321264-A1 SELECTIVE INHIBITORS OF GENOTOXIC STRESS-INDUCED IKK/NF-KB PATHWAYS Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (DE) 2018-05-16 EP disclosed